Item 7.01. Regulation FD Disclosure.
On March 17, 2026, InnovAge Holding Corp. (the "Company") will meet with investors and analysts at the KeyBank Capital Markets Healthcare Forum. At such meetings, the Company expects to reaffirms its full year fiscal year 2026 guidance as provided in its press release issued on February 3, 2026 in connection with the announcement of the Company's results for the second fiscal quarter ended December 31, 2026. A copy of the presentation to be used in connection with these meetings has been posted on the Company's Investor Relations website and is accessible to the public at https://investor.innovage.com.
The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section. This information shall not be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference to such disclosure in this Form 8-K in such a filing.